Page 463 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )

CHAPTER 22 ■ Lymphoid and Plasma Cell Neoplasms 447

F con . M inten nce ther py or ultiple yelo in the er o novel
COMPANION RES OURCES
gents, Hematology Am Soc Hematol Educ Program, 2015:279–284,

2015.
http://thepoint.lww.co / urgeon6e
Fer é C, et l. Che other py plus involve -f el r i tion in e rly-

E ch stu ent is encour ge to ccess n use the Web- st ge Ho gkin’s ise se, N Engl J Med, 357(19):1916–1927, 2007.

b se co p nion resources evelope or this ch pter. Fernàn ez V, et l. Gene expression prof le n geno ic ch nges in

Here, you will f n ition l le rning tools to incre se ise se progression o e rly-st ge chronic ly phocytic leuke i ,
Haematologica, 93(1):132–136, 2008.
your un erst n ing o the concepts n clinic l pplic - Ferry JA. Ly pho cl ssif c tion. In: Current Concepts in Clinical

tions o the ch pter.
Pathology, Boston, MA: Dep rt ent o P thology, M ss chusetts
Gener l Hospit l n H rv r Me ic l School, 2003:45–61.

Foubister V. Genes pointing the w y in ly pho prognosis, CAP

BIBLIOGRAPHY oday, 16(9):30–32, 2002.

Fröhling S, et l. Cytogenetics n ge re jor eter in nts o out-

Ar n P. Checkpoint block ge in ly pho , Hematology Am Soc co e in intensively tre te cute yeloi leuke i p tients ol er
Hematol Educ Program, 2015:69–72, 2015. th n 60 ye rs: results ro AMLSG tr il AML HD98-B, Blood,

Att l M, et l. M inten nce ther py with th li o i e i proves sur- 108(10):3280–3288, 2006.

viv l in p tients with ultiple yelo , Blood, 108(10):3289–3294, Ghiel ini M. Follicul r ly pho : che other py n /or ntibo ies?

2006. Blood, 108(10):3235, 2006.
Aw n F , et l. Mcl-1 expression pre icts progression- ree surviv l in H ll ert DYH. c-Abl kin se inhibitors overco e CD40- e i te rug

chronic ly phocytic leuke i p tients tre te with pentost tin, resist nce in CLL: i plic tions or ther peutic t rgeting o che o-

cyclophosph i e, n rituxi b, Blood, 113(3):535–537, 2009. resist nt niches, Blood, 112(13):5141–5149, 2008.

Ayli e MJ, et l. De onstr tion o ch nges in pl s cell subsets in H llek M. Che o-i unother py o CLL. In: Educational Book o the
ultiple yelo , Haematologica, 92(8):1135–1138, 2007. 8th Congress o the European Hematology Association, Lyon, Fr nce,

B sk r S, et l. A hu n onoclon l ntibo y rug n t rget iscov- 2003:175–179.

ery pl t or or B-cell chronic ly phocytic leuke i b se on llo- J e ES, et l. Cl ssif c tion o ly phoi neopl s s: the icroscope s

geneic he topoietic ste cell tr nspl nt tion n ph ge ispl y, tool or ise se iscovery, Blood, 112(12):4384–4399, 2008.
Blood, 114(20):4494–4502, 2009. K ter AP, et l. Cellul r i une ther py or chronic ly phocytic leu-

Be ven AW, Diehl LF. Peripher l -cell ly pho , NOS, n n pl stic ke i , Blood, 110(8):2811–2818, 2007.

l rge cell ly pho , Hematology Am Soc Hematol Educ Program, K y NE. re t ent n ev lu tion o CLL: co plic te ir, Blood,

2015:550–558, 2015. 107(3):848, 2006.
Bench AJ, et l. Molecul r genetic n lysis o h e tologic l lig- Kelly KM. Ho gkin ly pho in chil ren n olescents: i proving

n ncies II: ture ly phoi neopl s s, Int J Lab Hematol, 29(4): the ther peutic in ex, Hematology Am Soc Hematol Educ Program,

229–260, 2007. 126(22):514–520, 2015.

Binet J-L, et l. Perspectives on the use o new i gnostic tools in the Kobos R, erry W. A v nce in ther pies or non-Ho gkin ly pho
tre t ent o chronic ly phocytic leuke i , Blood, 107(3):859–861, in chil ren, Hematology Am Soc Hematol Educ Program, 2015:

2006. 522–528, 2015.

Blu KA. B-cell receptor p thw y o ul tors in NHL, Hematology Am Kyle RA, R jku r SV. Multiple yelo , Blood, 111(6):2962–2972,

Soc Hematol Educ Program, 2015:82–90, 2015. 2007.
Burger JA. Fle gling prognostic rkers in CLL, Blood, 110(12):3820– L bert MP. Chil hoo I P: knowing when to worry? Blood,

3821, 2007. 114(23):4758–4759, 2009.

Burger JA, et l. Ibrutinib s initi l ther py or p tients with chronic Lee RV, et l. B-cell ly pho with inter e i te- to high-gr e e -

ly phocytic leuke i , N Engl J Med, 373(25), 2425–2436, 2015. tures n i erent i unophenotypic prof les involving sep -
C lig ris-C ppio F. IG genes n h iry cell leuke i , Blood, r te n to ic sites with goo response to R-CHOP, Lab Med,

114(21):4610, 2009. 40(2):79–86, 2009.

C lin GA, Croce CM. Chronic ly phocytic leuke i : interpl y Lin P, Me eiros LJ. High-gr e B-cell ly pho /leuke i ssoci te

between nonco ing RNAs n protein-co ing genes, Blood, with t(14;18) n 8q24/MYC re rr nge ent: neopl s o ger i-
114(23):4761–4770, 2009. n l center i unophenotype with poor prognosis, Haematologica,

C lin GA, et l. A icroRNA sign ture ssoci te with prognosis 92(10):1297–1301, 2007.

n progression in chronic ly phocytic leuke i , N Engl J Med, Lokhorst HM, et l. rgeting CD38 with r tu u b onother py

353(17):1793–1801, 2005. in ultiple yelo , N Engl J Med, 373(13):1207–1220, 2015.
De r en C. M n ge ent o proly phocytic leuke i , Hematology Am Loni S, Nook AK. Novel co bin tion ppro ches or yelo ,

Soc Hematol Educ Program, 2015:361–366, 2015. Hematology Am Soc Hematol Educ Program, 2015:286–292,

Dicker F, et l. CD154 in uces p73 to overco e the resist nce to pop- 2015.

tosis o chronic ly phocytic leuke i cells l cking unction l p53, M yr C, et l. Chro oso l tr nsloc tions re ssoci te with poor
Blood, 108(10):3450–3457, 2006. prognosis in chronic ly phocytic leuke i , Blood, 107(2):742–751,

Diehl V, et l. St n r n incre se - ose BEACOPP che other py 2006.

co p re with COPP-ABVD or v nce Ho gkin’s ise se, Meht -Sh h N, Horwitz S. Zebr s n hen’s teeth: recognition n

N Engl J Med, 348(24):2386–2395, 2003. n ge ent o r re n NK ly pho s, Hematology Am Soc
Duvic M. Choosing syste ic tre t ent or v nce st ge cut ne- Hematol Educ Program, 2015:545–548, 2015.

ous -cell ly pho : ycosis ungoi es n Séz ry syn ro e, Mileshkin L, et l. P tients with ultiple yelo tre te with th -

Hematology Am Soc Hematol Educ Program, 2015:529–544, 2015. li o i e: ev lu tion o clinic l p r eters, cytokines, ngiogenic